WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani
M.D., Ph.D., President and Chief Executive Officer, is scheduled to
speak at the Canaccord Genuity Medical Technology and Diagnostics Forum
at the Westin Grand Central, New York, NY on November 19, 2015. Dr.
Gozani intends to provide an update on the Company's business activities
including the Quell® Wearable Pain Relief device.
NeuroMetrix's presentation is scheduled for Thursday, November 19, 2015
at 4:30 pm (Eastern Time). A live audio webcast will be available on the
investor relations section of the corporate website - http://www.NeuroMetrix.com/.
This webcast will be archived after the live event.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151112006001/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
